Utama › Keadaan Pasca-COVID (Long COVID) › New York › New York City
Kajian klinikal Keadaan Pasca-COVID (Long COVID) di New York City, NY
15 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Mengambil pesertaKajian pemerhatian
- Columbia University Medical Center, New York
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Mengambil pesertaFasa 3
- Weill Cornell Medical College ( Site 3814), New York
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Mengambil pesertaFasa 3
- Research Site, New York
Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
Mengambil pesertaFasa awal 1
- Weill Cornell Medicine, New York
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Mengambil pesertaSukarelawan sihat dialu-alukan
- Columbia University, New York
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Mengambil pesertaFasa 3
- Weill Cornell Medical College, New York
Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
Mengambil pesertaFasa 3
- Icahn School of Medicine at Mount Sinai, New York
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York
Antiviral Clinical Trial for Long Covid-19
Mengambil pesertaFasa 2
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE), New York
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Mengambil pesertaFasa 1/2
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE), New York
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- New York Presbyterian Queens, New York
- Weill Cornell Medicine/New-York Presbyterian Hospital, New York
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
Mengambil peserta
- New York University Grossman School of Medicine, New York
COVID-19 Survivorship Registry
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- NYU Langone Health, New York
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Mengambil pesertaFasa 3
- Columbia University Irving Medical Center, New York
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Mengambil pesertaFasa 3
- Memorial Sloan Kettering Cancer Center, New York
Kajian Keadaan Pasca-COVID (Long COVID) di bandar lain
- Houston, TX13 kajian
- Boston, MA13 kajian
- Baltimore, MD12 kajian
- Chicago, IL11 kajian
- Washington, DC10 kajian
- San Francisco, CA8 kajian
- Durham, NC8 kajian
- Atlanta, GA8 kajian
- San Diego, CA7 kajian
- Los Angeles, CA6 kajian
- Pittsburgh, PA6 kajian
- Hialeah, FL6 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.